Dalbavancin to Treat Infected Massive Endoprostheses: A Case Report and Cost Comparison Analysis

We report a case of an infected massive endoprosthetic replacement treated successfully with 2 stage surgery and off-label dalbavancin. Dalbavancin was used due to a limited number of antimicrobial options that could be administered safely in an outpatient setting and to avoid the need for daily dos...

Descripción completa

Detalles Bibliográficos
Autores principales: Azamgarhi, Tariq, Donaldson, James, Shah, Ashik, Warren, Simon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6831803/
https://www.ncbi.nlm.nih.gov/pubmed/31700772
http://dx.doi.org/10.7150/jbji.37980
_version_ 1783466054353158144
author Azamgarhi, Tariq
Donaldson, James
Shah, Ashik
Warren, Simon
author_facet Azamgarhi, Tariq
Donaldson, James
Shah, Ashik
Warren, Simon
author_sort Azamgarhi, Tariq
collection PubMed
description We report a case of an infected massive endoprosthetic replacement treated successfully with 2 stage surgery and off-label dalbavancin. Dalbavancin was used due to a limited number of antimicrobial options that could be administered safely in an outpatient setting and to avoid the need for daily dosing.
format Online
Article
Text
id pubmed-6831803
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Ivyspring International Publisher
record_format MEDLINE/PubMed
spelling pubmed-68318032019-11-07 Dalbavancin to Treat Infected Massive Endoprostheses: A Case Report and Cost Comparison Analysis Azamgarhi, Tariq Donaldson, James Shah, Ashik Warren, Simon J Bone Jt Infect Case Report We report a case of an infected massive endoprosthetic replacement treated successfully with 2 stage surgery and off-label dalbavancin. Dalbavancin was used due to a limited number of antimicrobial options that could be administered safely in an outpatient setting and to avoid the need for daily dosing. Ivyspring International Publisher 2019-10-15 /pmc/articles/PMC6831803/ /pubmed/31700772 http://dx.doi.org/10.7150/jbji.37980 Text en © The author(s) This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
spellingShingle Case Report
Azamgarhi, Tariq
Donaldson, James
Shah, Ashik
Warren, Simon
Dalbavancin to Treat Infected Massive Endoprostheses: A Case Report and Cost Comparison Analysis
title Dalbavancin to Treat Infected Massive Endoprostheses: A Case Report and Cost Comparison Analysis
title_full Dalbavancin to Treat Infected Massive Endoprostheses: A Case Report and Cost Comparison Analysis
title_fullStr Dalbavancin to Treat Infected Massive Endoprostheses: A Case Report and Cost Comparison Analysis
title_full_unstemmed Dalbavancin to Treat Infected Massive Endoprostheses: A Case Report and Cost Comparison Analysis
title_short Dalbavancin to Treat Infected Massive Endoprostheses: A Case Report and Cost Comparison Analysis
title_sort dalbavancin to treat infected massive endoprostheses: a case report and cost comparison analysis
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6831803/
https://www.ncbi.nlm.nih.gov/pubmed/31700772
http://dx.doi.org/10.7150/jbji.37980
work_keys_str_mv AT azamgarhitariq dalbavancintotreatinfectedmassiveendoprosthesesacasereportandcostcomparisonanalysis
AT donaldsonjames dalbavancintotreatinfectedmassiveendoprosthesesacasereportandcostcomparisonanalysis
AT shahashik dalbavancintotreatinfectedmassiveendoprosthesesacasereportandcostcomparisonanalysis
AT warrensimon dalbavancintotreatinfectedmassiveendoprosthesesacasereportandcostcomparisonanalysis

Ejemplares similares